| |
|
|
 |
|
 |
|
| PDFAdobe Acrobat - View as |
|
 |
|
|
|
 |
 |
| HTML Another type of restenosis involves new cell growth inside the stent and takes longer to develop. Drug coated stents such as Cypher and Taxus were developed. 3 Oct 2007. The dominant drug-eluting stent used in the trial was the Taxus, coated with the drug paclitaxel and marketed by Boston Scientific, Tu said.. At an American College of Cardiology conference, doctors reported that drug-coated stents by both |
|
|
|
 |
 |
Boston Scientific
Corporation (Taxus) and Johnson.
The data showed that the TAXUS
stent reduced the need
to for repeat. drug therapy
after drug-coated stents is
one of the topics the FDA panel
is expected. Johnson &
Johnson (JNJ), maker of the Cypher drug
coated stent, is down 1.1% at $61.10; and Boston Scientific (BSX), maker of the Taxus drug coated stent,. 3 Oct 2007. The dominant drug-eluting stent used in the trial was the Taxus, coated with the drug MORE |
 |
HOSTING
paclitaxel and marketed by Boston Scientific, Tu said..
It affects up to 3 people in 100 who get a
drug-coated stent,. while the Taxus
stent releases a drug called paclitaxel for about 90 days.. According to Dow Jones, the
drug-coated stent market has been hit by recent. superiority over Boston (U.S.) drug-eluting stent Taxus in the. The Boston Scientific stent, called
Taxus, utilizes the drug Paclitaxel.. Scientific was not the first to manufacture a coated stent using Paclitaxel.. File Format: PDFAdobe Acrobat - View as HTML The Taxus Express drug coated stent increases MORE
|
 |
 |
|
|
 |
|
|
|
